Triasima Portfolio Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,244
Closed -$1.11M 146
2024
Q4
$1.11M Sell
4,244
-7,138
-63% -$2.12M 0.21% 103
2024
Q3
$3.67M Buy
11,382
+174
+2% +$56.9K 0.82% 43
2024
Q2
$3.5M Buy
11,208
+155
+1% +$45.5K 0.32% 55
2024
Q1
$3.14M Buy
+11,053
New +$3.23M 0.26% 66
2021
Q1
Sell
-885
Closed -$203K 177
2020
Q4
$203K Buy
+885
New +$204K 0.01% 155

Other funds holding AMGN

Triasima Portfolio Management's AMGN Position: Q1 2025 in Review

Triasima Portfolio Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 4,244 shares — an estimated $1.11M sold.

Triasima Portfolio Management first reported a position in AMGN in Q4 2020 and held it in 5 quarters. The position peaked at $3.67M in Q3 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Triasima Portfolio Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Triasima Portfolio Management sold 4,244 Amgen shares in Q1 2025, an estimated $1.11M.
  • Triasima Portfolio Management first reported a position in Amgen in Q4 2020 and held it in 5 quarters.
  • Triasima Portfolio Management's Amgen position peaked at $3.67M in Q3 2024.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Triasima Portfolio Management's 13F filing for Q1 2025, filed 2 May 2025.